We analyzed the proteomic profiles of patients with CHB, LC, and HCC and HCs using sEVs and identified five biomarkers, namely CO9, LBP, SVEP1, VWF, and KV311. This evidence concerns the gene PSPHP1 and laryngotracheoesophageal cleft.